Epidemiology and risk factors of the cardiometabolic syndrome in the Middle East

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 3, 2011, Pages 309-320

  Ashraf, Haleh ^a   Rashidi, Armin ^b   Noshad, Sina ^c   Khalilzadeh, Omid ^c   Esteghamati, Alireza ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

diabetes; dyslipidemia; metabolic syndrome; Middle East; obesity; risk factor

Indexed keywords

BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DYSLIPIDEMIA; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; METABOLIC SYNDROME X; MIDDLE EAST; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; REVIEW; RISK FACTOR;

EID: 79953251689     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.11.9     Document Type: Review

References (113)

1. Poirier P, Giles TD, Bray GA et al. Obesity and cardiovascular disease: Pathophysiology, evaluation and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity and Metabolism. Circulation 113(6), 898-918 (2006).
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285(19), 2486-2497 (2001).
3. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 366(9491), 1059-1062 (2005). (Pubitemid 41338752)
4. Despres JP, Arsenault BJ, Cote M, Cartier A, Lemieux I. Abdominal obesity: The cholesterol of the 21st Century? Can. J. Cardiol. 24(Suppl. D), 7D-12D (2008). Review of obesity and particularly abdominal obesity, and its association with cardiovascular disease morbidity. Provides general approaches to fight obesity and highlights the challenges involved.
5. Prentice AM. The emerging epidemic of obesity in developing countries. Int. J. Epidemiol. 35(1), 93-99 (2006). (Pubitemid 43205453)
6. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet 360(9343), 1347-1360 (2002). (Pubitemid 35341298)
7. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L. Obesity in adulthood and its consequences for life expectancy: A life-table analysis. Ann. Intern. Med. 138(1), 24-32 (2003). (Pubitemid 36232091)
8. James WPT, Jackson-Leach R, Mhurchu C et al. Overweight and obesity (high body mass index). In:Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Ezzati M, Lopez AD, Rodgers A, Murray CJ (Eds). WHO, Geneva, Switzerland (2004).
9. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Arch. Intern. Med. 162(16), 1867-1872 (2002). This classical Framingham study shows that the overweight category (BMI 25-30 kg/m2) is associated with increased relative and population-attributable risk for hypertension and cardiovascular sequelae.
10. Kenchaiah S, Evans JC, Levy D et al. Obesity and the risk of heart failure. N. Engl. J. Med. 347(5), 305-313 (2002). (Pubitemid 34815352)
11. Motlagh B, O'Donnell M, Yusuf S. Prevalence of cardiovascular risk factors in the Middle East: A systematic review. Eur. J. Cardiovasc. Prev. Rehabil. 16(3), 268-280 (2009). This systematic review estimates that the prevalence of obesity and diabetes in the Middle East is 24.5 and 10.5%, respectively.
12. Esteghamati A, Meysamie A, Khalilzadeh O et al. Third National Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: Methods and results on prevalence of diabetes, hypertension, obesity, central obesity and dyslipidemia. BMC Public Health 9, 167 (2009).
13. Esteghamati A, Khalilzadeh O, Mohammad K et al. Secular trends of obesity in Iran between 1999 and 2007: National Surveys of Risk Factors of Non-Communicable Diseases. Metab. Syndr. Relat. Disord. 8(3), 209-213 (2010).
14. al-Isa AN. Changes in body mass index (BMI) and prevalence of obesity among Kuwaitis 1980-1994. Int. J. Obes. Relat. Metab. Disord. 21(12), 1093-1099 (1997). (Pubitemid 27511481)
15. Al-Lawati JA, Jousilahti PJ. Prevalence and 10-year secular trend of obesity in Oman. Saudi. Med. J. 25(3), 346-351 (2004). (Pubitemid 38461100)
16. Sheffer R, Calderon-Margalit R. Trends in overweight, obesity and blood pressure among Israeli working adults - implications for public health. Eur. J. Public Health 18(2), 121-125 (2008). (Pubitemid 351398369)
17. Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative bodyweight and human adiposity. Behav. Genet. 27(4), 325-351 (1997). (Pubitemid 27415169)
18. Hinney A, Vogel CI, Hebebrand J. From monogenic to polygenic obesity: Recent advances. Eur. Child Adolesc. Psychiatry 19(3), 297-310 (2010).
19. Haslam DW, James WP. Obesity. Lancet 366(9492), 1197-1209 (2005). (Pubitemid 41393598)
20. Esteghamati A, Khalilzadeh O, Anvari M, Rashidi A, Mokhtari M, Nakhjavani M. Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome:the key role of central obesity. Metab. Syndr. Relat. Disord. 7(5), 447-452 (2009).
21. Galal O. Nutrition-related health patterns in the Middle East. Asia Pac. J. Clin. Nutr. 12(3), 337-343 (2003). (Pubitemid 38880721)
22. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates and projections. Diabetes Care 21(9), 1414-1431 (1998). (Pubitemid 28405191)
23. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 27(5), 1047-1053 (2004). (Pubitemid 38579764)
24. Chan JC, Malik V, Jia W et al. Diabetes in Asia: Epidemiology, risk factors and pathophysiology. JAMA 301(20), 2129-2140 (2009).
25. Abdella N, Al Arouj M, Al Nakhi A, Al Assoussi A, Moussa M. Non-insulin-dependent diabetes in Kuwait: Prevalence rates and associated risk factors. Diabetes Res. Clin. Pract. 42(3), 187-196 (1998). (Pubitemid 29009780)
26. Esteghamati A, Khalilzadeh O, Anvari M et al. The economic costs of diabetes: A population-based study in Tehran, Iran. Diabetologia 52(8), 1520-1527 (2009).
27. Jeon CY, Lokken RP, Hu FB, van Dam RM. Physical activity of moderate intensity and risk of Type 2 diabetes: A systematic review. Diabetes Care 30(3), 744-752 (2007). This review of ten prospective cohort studies demonstrates that moderate levels of physical activity, such as brisk walking, reduced the risk of developing diabetes by approximately 30%. (Pubitemid 46357402)
28. Ahmed Khoja T, Al-Shoumer K, Sulimani R et al. Diabetes: The hidden pandemic and its impact on the Middle East and Northen Africa (MENA). Dubai (2010).
29. International Diabetes Federation. IDF Diabetes Atlas (4th Edition). International Diabetes Federation, Brussels, Belgium (2009).
30. Esteghamati A, Ashraf H, Khalilzadeh O et al. Trends of diabetes according to body mass index levels in Iran: Results of the national Surveys of Risk Factors of Non-Communicable Diseases (1999-2007). Diabet. Med. 27(11), 1233-1240 (2010).
31. Esteghamati A, Gouya MM, Abbasi M et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care 31(1), 96-98 (2008).
32. El-kebbi IM, Engelgau MM. The burden of diabetes and its complications in the Middle East and Eastern Mediterranean region. In:The Epidemiology of Diabetes Mellitus Ekoé JM, Rewers M, Williams R, Zimmet P (Eds). John Wiley & Sons, Ltd, Chichester, UK, 121-131 (2008).
33. Mansour AA, Wanoose HL, Hani I, Abed-Alzahrea A, Wanoose HL. Diabetes screening in Basrah, Iraq: A population-based cross-sectional study. Diabetes Res. Clin. Pract. 79(1), 147-150 (2008).
34. Shera AS, Rafique G, Khawaja IA, Baqai S, King H. Pakistan National Diabetes Survey: Prevalence of glucose intolerance and associated factors in Baluchistan province. Diabetes Res. Clin. Pract. 44(1), 49-58 (1999). (Pubitemid 29446189)
35. Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys. Ther. 88, 1254-1264 (2008).
36. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 414, 782-787 (2001). (Pubitemid 34000780)
37. Bamba V, Rader DJ. Obesity and atherogenic dyslipidemia. Gastroenterology 132, 2181-2190 (2007). (Pubitemid 46693753)
38. Lopez AD. Global Burden of Disease and Risk Factors. Mathers D, Ezzati M, Jamison DT, Murray C (Eds). World Bank, Washington DC, USA (2006).
39. WHO. Chapter 4: Quantifying selected major risks to health. In: The World Health Report 2002 - Reducing Risks, Promoting Healthy Life. WHO, Geneva, Switzerland, 47-97 (2002).
40. Dickinson S, Colagiuri S, Faramus E, Petocz P, Brand-Miller JC. Postprandial hyperglycemia and insulin sensitivity differ among lean young adults of different ethnicities. J. Nutr. 132(9), 2574-2579 (2002). (Pubitemid 35013236)
41. Wu Y, Li H, Loos RJ et al. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8 and HHEX/IDE genes are associated with Type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes Care 57(10), 2834-2842 (2008).
42. Yokoi N, Kanamori M, Horikawa Y et al. Association studies of variants in the genes involved in pancreatic b-cell function in Type 2 diabetes in Japanese subjects. Diabetes Care 55(8), 2379-2386 (2006). (Pubitemid 44743638)
43. Esteghamati A, Khalilzadeh O, Anvari M, Seyed Ahadi M, Abbasi M, RashidiA. Metabolic syndrome and insulin resistance significantly correlate with body mass index. Arch. Med. Res. 39, 803-808 (2008).
44. Esteghamati A, Ashraf H, Rashidi A, Meysamie A. Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults. Diabetes Res. Clin. Pract. 82(1), 104-107 (2008).
45. Esteghamati A, Zandieh A, Khalilzadeh O, Morteza A, Meysamie A, Nakhjavani M, Gouya MM. Clustering of leptin and physical activity with components of metabolic syndrome in Iranian population: An exploratory factor analysis. Endocrine 38, 206-213 (2010).
46. Esteghamati A, Khalilzadeh O, Rashidi A, Kamgar M, Meysamie A, Abbasi M. Physical activity in Iran: Results of the Third National Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007). J. Phys. Act. Health 8(1), 27-35 (2011).
47. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 29(9), 2114-2116 (2006). (Pubitemid 44871196)
48. Malik VS, Schulze MB, Hu FB. Intake of sugarsweetened beverages and weight gain: A systematic review. Am. J. Clin. Nutr. 84, 274-288 (2006). (Pubitemid 44699135)
49. Will JC, Galuska DA, Ford ES, Mokdad A, Calle EE. Cigarette smoking and diabetes mellitus: Evidence of a positive association from a large prospective cohort study. Int. J. Epidemiol. 30, 540-546 (2001). (Pubitemid 32600247)
50. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of Type 2 diabetes: A systematic review and meta-analysis. JAMA 298, 2654-2664 (2007). (Pubitemid 350254957)
51. Meysamie A, Ghaletaki R, Haghazali M et al. Pattern of tobacco use among the Iranian adult population: Results of the national Survey of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007). Tob. Control 19, 125-128 (2010).
52. Smith DG. Epidemiology of dyslipidemia and economic burden on the healthcare system. Am. J. Manag. Care 13(Suppl. 3), S68-S71 (2007).
53. Jackson RT, al-Mousa Z, al-Raqua M, Prakash P, Muhanna A. Prevalence of coronary risk factors in healthy adult Kuwaitis. Int. J. Food Sci. Nutr. 52, 301-311 (2001). (Pubitemid 32677277)
54. Olusi SO, Al-Awadi AM, Abraham M. Baseline population survey data on the prevalence of risk factors for coronary artery disease among Kuwaitis aged 15 years and older. Ann. Saudi. Med. 23, 162-166 (2003). (Pubitemid 37045749)
55. Centers for Disease Control and Prevention (CDC). State-specific cholesterol screening trends: United States, 1991-1999. MMWR Morb. Mortal. Wkly. Rep. 49, 750-755 (2000).
56. Al-Nuaim AR, Al-Rubeaan K, Al-Mazrou Y, Al-Attas O, Al-Daghari N. Prevalence of hypercholesterolemia in Saudi Arabia, epidemiological study. Int. J. Cardiol. 54, 41-49 (1996). (Pubitemid 26179512)
57. Mahley RW, Palaoglu KE, Atak Z et al. Turkish Heart Study: Lipids, lipoproteins and apolipoproteins. J. Lipid Res. 36, 839-859 (1995).
58. Al-Riyami AA, Afifi MM. Prevalence and correlates of obesity and central obesity among Omani adults. Saudi. Med. J. 24, 641-646 (2003). (Pubitemid 36833558)
59. Lloyd-Jones D, Adams R, Carnethon M et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2009 Update A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119, e21-e181 (2009).
60. Firmann M, Mayor V, Vidal PM et al. The CoLaus study: A population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc. Disord. 8, 6 (2008).
61. Al-Nozha MM, Arafah MR, Al-Maatouq MA et al. Hyperlipidemia in Saudi Arabia. Saudi. Med. J. 29, 282-287 (2008). (Pubitemid 351385134)
62. Erem C, Hacihasanoglu A, Deger O et al. Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study. Endocrine 33, 9-20 (2008).
63. Sibai AM, Obeid OA, Batal M, Adra N, Dit El Khoury DT, Hwalla N. Prevalence and correlates of metabolic syndrome in an adult Lebanese population. Prev. Control 3, 83-90 (2008). (Pubitemid 351966354)
64. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 287(3), 356-359 (2002). (Pubitemid 34251969)
65. Miccoli R, Bianchi C, Odoguardi L et al. Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr. Metab. Cardiovasc. Dis. 15, 250-254 (2005). (Pubitemid 41190981)
66. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41(6), 715-722 (1992).
67. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 23(5), 469-480 (2006).
68. Yoon YS, Lee ES, Park C, Lee S, Oh SW. The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: The Korea NHANES study. Int. J. Obes. 31(3), 528-534 (2007).
69. Tong PC, Kong AP, So WY et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with Type 2 diabetes. Diabetes Care 30(5), 1206-1211 (2007). One of the first studies that demonstrated that the definition of the metabolic syndrome may need to be ethnicity specific. The International Diabetes Federation definition underestimates the prevalence of the metabolic syndrome in some Asian countries. (Pubitemid 46684649)
70. Esteghamati A, Abbasi M, Rashidi A et al. Optimal waist circumference cutoffs for the diagnosis of metabolic syndrome in Iranian adults: Results of the third national survey of risk factors of non-communicable diseases (SuRFNCD-2007). Diabet. Med. 26(7), 745-746 (2009). This brief report demonstrates a successful example of how the optimal waist circumference cut-off for the diagnosis of the metabolic syndrome may be derived from a nationally representative survey. It also includes references to details of how such a survey can be designed and conducted. This article has established the optimal waist cut-off for Iran at 90 cm for both men and women.
71. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: A prospective cohort study. Atherosclerosis 191(1), 182-190 (2007). (Pubitemid 46237629)
72. Al Rashdan I, Al Nesef Y. Prevalence of overweight, obesity and metabolic syndrome among adult Kuwaitis: Results from community-based national survey. Angiology 61(1), 42-48 (2010).
73. Mansour AA, Al-Hassan AA, Al-Jazairi MI. Cut-off values for waist circumference in rural Iraqi adults for the diagnosis of metabolic syndrome. Rural Remote Health 7(4), 765 (2007).
74. Maggi S, Noale M, Gallina P et al. Metabolic syndrome, diabetes and cardiovascular disease in an elderly Caucasian cohort: The Italian Longitudinal Study on Aging. J. Gerontol. A. Biol. Sci. Med. Sci. 61(5), 505-510 (2006). (Pubitemid 43794711)
75. Patel A, Huang KC, Janus ED et al. Is a single definition of the metabolic syndrome appropriate? A comparative study of the USA and Asia. Atherosclerosis 184(1), 225-232 (2006). (Pubitemid 41721092)
76. Kozan O, Oguz A, Abaci A et al. Prevalence of the metabolic syndrome among Turkish adults. Eur. J. Clin. Nutr. 61(4), 548-553 (2007). (Pubitemid 46605227)
77. Malik M, Razig SA. The prevalence of the metabolic syndrome among the multiethnic population of the United Arab Emirates: A report of a national survey. Metab. Syndr. Relat. Disord. 6(3), 177-186 (2008).
78. Bener A, Zirie M, Musallam M, Khader YS, Al-Hamaq AO. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: A population-based study. Metab. Syndr. Relat. Disord. 7(3), 221-229 (2009).
79. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Sabico SL, Chrousos GP. Decreasing prevalence of the full metabolic syndrome but a persistently high prevalence of dyslipidemia among adult Arabs. PLoS One 5(8), e12159 (2010).
80. Esteghamati A, Khalilzadeh O, Rashidi A et al. Association between physical activity and metabolic syndrome in Iranian adults: National surveillance of risk factors of noncommunicable diseases (SuRFNCD-2007). Metabolism 58(9), 1347-1355 (2009).
81. Mabry RM, Reeves MM, Eakin EG, Owen N. Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: A systematic review. Diabet. Med. 27(5), 593-597 (2010).
82. Sanisoglu SY, Oktenli C, Hasimi A, Yokusoglu M, Ugurlu M. Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey. BMC Public Health 6, 92 (2006).
83. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT et al. Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. Diabetes Care 29(3), 685-691 (2006). (Pubitemid 44115374)
84. Feng Y, Hong X, Li Z et al. Prevalence of metabolic syndrome and its relation to body composition in a Chinese rural population. Obesity (Silver Spring) 14(11), 2089-2098 (2006). (Pubitemid 46127365)
85. Al-Nozha M, Al-Khadra A, Arafah MR et al. Metabolic syndrome in Saudi Arabia. Saudi. Med. J. 26(12), 1918-1925 (2005). (Pubitemid 43180350)
86. Thomas GN, Ho SY, Janus ED, Lam KS, Hedley AJ, Lam TH. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res. Clin. Pract. 67(3), 251-257 (2005). (Pubitemid 40254315)
87. McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 87(1), 152-161 (1993). (Pubitemid 23019345)
88. Whincup PH, Gilg JA, Papacosta O et al. Early evidence of ethnic differences in cardiovascular risk: Cross sectional comparison of British South Asian and white children. BMJ 324(7338), 635 (2002).
89. Al-Nozha MM, Al-Mazrou YY, Al-Maatouq MA et al. Obesity in Saudi Arabia. Saudi. Med. J. 26(5), 824-829 (2005). (Pubitemid 40903350)
90. Al-Tawil NG, Abdulla MM, Abdul Ameer AJ. Prevalence of and factors associated with overweight and obesity among a group of Iraqi women. East Mediterr. Health J. 13(2), 420-429 (2007). (Pubitemid 47046006)
91. Berrios X, Koponen T, Huiguang T, Khaltaev N, Puska P, Nissinen A. Distribution and prevalence of major risk factors of noncommunicable diseases in selected countries: The WHO Inter-Health Programme. Bull. World Health Organ. 75(2), 99-108 (1997). (Pubitemid 27271462)
92. Iseri A, Arslan N. Obesity in adults in Turkey: Age and regional effects. Eur. J. Public Health 19(1), 91-94 (2009).
93. Keinan-Boker L, Noyman N, Chinich A, Green MS, Nitzan-Kaluski D. Overweight and obesity prevalence in Israel: Findings of the first national health and nutrition survey (MABAT). Isr. Med. Assoc. J. 7(4), 219-223 (2005). (Pubitemid 40528807)
94. Malik M, Bakir A, Saab BA, King H. Glucose intolerance and associated factors in the multi-ethnic population of the United Arab Emirates: Results of a national survey. Diabetes Res. Clin. Pract. 69, 188-195 (2005). (Pubitemid 40943485)
95. Maziak W, Rastam S, Mzayek F, Ward KD, Eissenberg T, Keil U. Cardiovascular health among adults in Syria: A model from developing countries. Ann. Epidemiol. 17(9), 713-720 (2007). (Pubitemid 47277513)
96. Moosa K, Abdul Wahab AW, Gharib N, Al Sairafi M, Al Raees G, Al Amer M. National Nutrition Survey for Adult Bahrainis Aged 19 Years and Above. Kingdom of Bahrain Ministry of Health, Bahrain (2002).
97. Sibai AM, Hwalla N, Adra N, Rahal B. Prevalence and covariates of obesity in Lebanon: Findings from the first epidemiological study. Obes. Res. 11(11), 1353-1361 (2003). (Pubitemid 41127357)
98. Stene LC, Giacaman R, Abdul-Rahim H, Husseini A, Norum KR, Holmboe-Ottesen G. Obesity and associated factors in a Palestinian West Bank village population. Eur. J. Clin. Nutr. 55(9), 805-811 (2001). (Pubitemid 32834397)
99. Zindah M, Belbeisi A, Walke H, Mokdad AH. Obesity and diabetes in Jordan: Findings from the behavioral risk factor surveillance system, 2004. Prev. Chronic. Dis. 5(1), A17 (2008).
100. Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Gordon NH, Jervell J. The metabolic syndrome in the West Bank population: An urban-rural comparison. Diabetes Care 24(2), 275-279 (2001). (Pubitemid 32119124)
101. Albache N, Al Ali R, Rastam S, Fouad FM, Mzayek F, Maziak W. Epidemiology of Type 2 diabetes mellitus in Aleppo, Syria. J. Diabetes 2(2), 85-91 (2010).
102. Al-Moosa S, Allin S, Jemiai N, Al-Lawati J, Mossialos E. Diabetes and urbanization in the Omani population: An analysis of National Survey data. Popul. Health Metr. 4, 5 (2006).
103. Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY et al. Diabetes mellitus in Saudi Arabia. Saudi. Med. J. 25, 1603-1610 (2004). (Pubitemid 39646631)
104. Bener A, Zirie M, Janahi I, Al-Hamaq A, Musallam M, Wareham N. Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar. Diabetes Res. Clin. Pract. 84, 99-106 (2009).
105. Chodick G, Heymann AD, Shalev V, Kookia E. The epidemiology of diabetes in a large Israeli HMO. Eur. J. Epidemiol. 18, 1143-1146 (2003). (Pubitemid 38083960)
106. Herman WH, Aubert RE, Ali MA, Sous ES, Badran A. Diabetes mellitus in Egypt: Risk factors, prevalence and future burden. East Mediter. Health J. 3, 144-148 (1997). (Pubitemid 127468691)
107. Hirbli KI, Jambeine MA, Slim HB, Barakat WM, Habis RJ, Francis ZM. Prevalence of diabetes in greater Beirut. Diabetes Care 28, 1262 (2005).
108. Loizou T, Pouloukas S, Tountas C, Thanopoulou A, Karamanos V. An epidemiologic study on the prevalence of diabetes, glucose intolerance and metabolic syndrome in the adult population of the Republic of Cyprus. Diabetes Care 29, 1714-1715 (2006). (Pubitemid 44127617)
109. Satman I, Yilmaz T, Sengül A et al. Population-based study of diabetes and risk characteristics in Turkey. Diabetes Care 25(9), 1551-1556 (2002).
110. Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 26(6), 1781-1785 (2003). (Pubitemid 36929119)
111. Erem C, Hacihasanoglu A, Deger O, Kocak M, Topbas M. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study. Endocrine 34, 36-51 (2008).
112. Khader YS, Batieha A, El-Khateeb M, Omari M, Ajlouni K. Prevalence of dyslipidemia and its associated factors among Jordanian adults. J. Clin. Lipidol. 4, 53-58 (2010).
113. Mula-Abed WA, Chilmeran SK. Prevalence of dyslipidemia in the Iraqi adult population. Saudi. Med. J. 28, 1868-1874 (2007). (Pubitemid 351863922)